<DOC>
	<DOCNO>NCT03038633</DOCNO>
	<brief_summary>This Phase 1 clinical trial design evaluate safety tolerability novel medical food utilize nutritional strain yeast management Iron Deficiency Anemia .</brief_summary>
	<brief_title>A Trial Evaluate Safety Tolerability Novel Medical Food Management Iron Deficiency Anemia</brief_title>
	<detailed_description>The investigational product medical food result discovery follow extensive research two preclinical model carry team researcher Penn State University . This study utilize standard `` 3+3 '' rule-based dose-escalation scheme , use predetermine dose level cohort three patient . The total time commitment subject approximately three month .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Hemoglobin , ( Hgb ) 710 g/dL ; transferrin saturation &lt; 20 % ; serum ferritin &lt; 20ng/mL Pregnant sexuallyactive female subject childbearing potential willing use acceptable form contraception ( tubal ligation otherwise incapable pregnancy , hormonal contraceptive , spermicide plus barrier intrauterine device ) . Present consumption iron supplement multivitamins must switch vitamin contain iron , multivitamin Centrum Silver . No washout period necessary since apparent ongoing anemia current supplement ineffective . Current anemia attribute immune deficiency , ( ID ) ( e.g . microcytic anemia hemolytic , macrocytic , sideroblastic myelosuppression chemotherapy radiotherapy induce anemia ) . Active malignancy within 1 year . Basal squamous cell skin cancer exclusionary . Aspartate Aminotransferase , ( AST ) Alanine Aminotransferase , ( ALT ) screen great 1.5 time upper limit normal . Known positive hepatitis B evidence active hepatitis . Known positive HIV1/HIV2 antibody ( antiHIV ) . Patient current diagnosis asthma actively use antiasthmatic therapy . Received investigational drug within 30 day screen . Hemochromatosis iron storage disorder . Unregulated hypertension Chronic kidney disease . Chronic inflammatory condition include limited Lupus Rheumatoid Arthritis . Significant cardiovascular disease , include limited myocardial infarction unstable angina within 6 month prior study inclusion current history New York Heart Association , ( NYHA ) Class III IV congestive heart failure . Smoking Irritable Bowel Syndrome Any laboratory abnormality , medical condition psychiatric disorder opinion investigator put subject 's disease management risk may result subject unable comply study requirement . Breastfeeding plan enrol study . Known allergy yeast Currently Monoamine oxidase inhibitor , ( MAOI 's ) Demerol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>